Axita
Axita is Axitinib, an oral VEGFR tyrosine kinase inhibitor. It is indicated for advanced renal cell carcinoma and works by inhibiting angiogenesis and reducing the tumor blood supply.
Features
| Product Name | Axita |
| Generic Name | Axitinib |
| Formulation | Tablet |
| Available Pack Size | 2X10's |
| Available Strength | 5MG |